Skip to main content
LobbyMap

Jazz Pharmaceuticals

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
56/100
Moderate Influence
$3.4M
Total Lobby Spend
3
Policy Issues
2
Lobbyists
1
Revolving Door

Jazz Pharmaceuticals reported $3.4 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 3 policy areas, with primary focus on Health Issues, Pharmacy, Government Issues. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Office of the U.S. Trade Representative
Dept of Energy
Dept of the Treasury
Dept of Labor
Federal Trade Commission
Dept of Housing & Urban Development

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecVenable LLP
GOVPHAHCR
1$176K
2024 Jul-SepSubject Matter
HCRPHAGOV
2$145K
2024 Apr-JunCassidy & Associates
PHAHCR
2$145K
2024 Jan-MarVenable LLP
PHAGOV
1$163K
2023 Oct-DecMehlman Consulting
PHAGOVHCR
2$171K
2023 Jul-SepPodesta Group
GOVHCRPHA
2$178K
2023 Apr-JunSummit Strategies Government Affairs
HCRGOV
1$204K
2023 Jan-MarBrownstein Hyatt Farber Schreck
PHAGOVHCR
1$198K

Jazz Pharmaceuticals Lobbying FAQ

Jazz Pharmaceuticals has spent $3.4M on federal lobbying across 3 policy areas. This includes spending on registered lobbyists and direct government contacts.

Jazz Pharmaceuticals lobbies on 3 policy issues, including Health Issues, Pharmacy, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Jazz Pharmaceuticals has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Jazz Pharmaceuticals employs 2 registered lobbyists, of whom 1 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Jazz Pharmaceuticals has contacted 6 government entities as part of their lobbying activities, including Office of the U.S. Trade Representative, Dept of Energy, Dept of the Treasury.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.